Leo Cancer Care Secures $65 Million to Transform Radiation Therapy
Medical technology innovator Leo Cancer Care has successfully secured a $65 million Series D funding round aimed at advancing its groundbreaking radiation therapy solution. The funds will be directed toward scaling the company’s unique approach to treating cancer through upright patient positioning, a method poised to redefine cancer care.
Investment Led by Silicon Valley’s You Are the Galaxy
The investment round was spearheaded by Silicon Valley’s You Are the Galaxy, with participation from new investors such as Eventide Asset Management, as well as ongoing backing from existing supporters. Since its founding in 2018, Leo Cancer Care has amassed $155 million in funding to further its innovative technology.
Scaling and Strategic Partnerships
Leo Cancer Care intends to utilize the new capital to enhance production capabilities and expedite the commercial availability of its integrated upright platform. This platform encompasses proton therapy, photon therapy, and imaging, creating a seamless approach from diagnosis through treatment. The company has also formed a strategic alliance with a major international healthcare entity, whose identity remains undisclosed.
Revolutionizing Radiation Therapy
The company was born from a simple yet revolutionary idea: treating patients in an upright position rather than lying flat. This method not only promises a more compassionate treatment experience but also reduces the size, cost, and complexity of current radiation therapy systems. Leo Cancer Care’s technology could potentially cut the cost of proton therapy systems by half.
Patient-Centric Approach
Patients benefit from a more interactive experience, maintaining eye contact and communication with their healthcare team throughout the treatment process. This patient-centric philosophy is central to Leo Cancer Care’s mission to simplify and humanize radiation therapy.
Leadership and Innovation
Co-founded by CEO Stephen Towe and medical technology entrepreneur Rock Mackie, Leo Cancer Care draws on expertise from the University of Sydney. Towe, a former physicist at Elekta, sought to innovate by revisiting the fundamentals of radiation therapy rather than adding complexity to existing models.
Making Cancer Treatment Accessible
By maintaining a fixed radiation beam and rotating the patient, Leo Cancer Care has significantly reduced machine size and costs, projecting substantial savings for healthcare providers. The company’s ultra-compact accelerators reduce the traditional footprint, transforming installation into a straightforward process.
Global Impact and Future Prospects
The company has already seen success, with institutions like Stanford Medicine pioneering the use of its technology. Leading cancer centers such as Dana-Farber Cancer Institute and McLaren Health Care are also adopting this approach. With 57 contracts across 13 countries, Leo Cancer Care is set for robust growth.
As Leo Cancer Care continues to expand, future applications are anticipated beyond radiation oncology into broader radiology domains. The company aims to challenge traditional treatment paradigms by promoting upright procedures across various clinical applications.
Leo Cancer Care’s advancements are expected to democratize access to innovative cancer treatments globally, as noted by PR Yu, founder of Yu Galaxy. This expansion offers unprecedented opportunities in radiation therapy and diagnostic radiology, particularly benefiting pediatric and larger-sized patients.
For further details, visit the source link: Here.
“`
